Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10009597HBVENSG00000064989.13protein_codingCALCRLNoNo10203Q16602
TVIS10011300HBVENSG00000064989.13protein_codingCALCRLNoNo10203Q16602
TVIS10041989HBVENSG00000064989.13protein_codingCALCRLNoNo10203Q16602
TVIS30051950HIVENSG00000064989.13protein_codingCALCRLNoNo10203Q16602
TVIS20000113HPVENSG00000064989.13protein_codingCALCRLNoNo10203Q16602
TVIS20001686HPVENSG00000064989.13protein_codingCALCRLNoNo10203Q16602
TVIS44048722HTLV-1ENSG00000064989.13protein_codingCALCRLNoNo10203Q16602
TCGA Plot Options
Drug Information
GeneCALCRL
DrugBank IDDB12457
Drug NameRimegepant
Target IDBE0009009
UniProt IDQ16602
Regulation Typeantagonist
PubMed IDs31291516; 31081399
CitationsLipton RB, Croop R, Stock EG, Stock DA, Morris BA, Frost M, Dubowchik GM, Conway CM, Coric V, Goadsby PJ: Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine. N Engl J Med. 2019 Jul 11;381(2):142-149. doi: 10.1056/NEJMoa1811090.@@Negro A, Martelletti P: Gepants for the treatment of migraine. Expert Opin Investig Drugs. 2019 Jun;28(6):555-567. doi: 10.1080/13543784.2019.1618830. Epub 2019 May 17.
GroupsApproved; Investigational
Direct ClassificationImidazopyridines
SMILESN[C@H]1[C@@H](CC[C@@H](OC(=O)N2CCC(CC2)N2C(=O)NC3=NC=CC=C23)C2=C1C=CC=N2)C1=C(F)C(F)=CC=C1
Pathways
PharmGKB
ChEMBLCHEMBL2178422